The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albina, J. E.
Right arrow Articles by Reichner, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albina, J. E.
Right arrow Articles by Reichner, J. S.

The Journal of Immunology, Vol 157, Issue 1 279-283, Copyright © 1996 by American Association of Immunologists

ARTICLES

B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity

JE Albina, BA Martin, WL Henry Jr, CA Louis and JS Reichner
Department of Surgery, Rhode Island Hospital, Providence 02903, USA.

Activated murine peritoneal macrophage cytotoxicity against P815 tumor cells has been shown to be mediated by the reactive nitrogen intermediates (RNI) produced by macrophages from L-arginine through nitric oxide (NO) synthase. Previous results from this laboratory indicated that NO-dependent killing of P815 fulfilled the criteria for apoptotic death. Work by others, in turn, demonstrated that the product of the bcl-2 gene confers protection against various inducers of apoptosis, including reactive oxygen intermediates. Experiments were performed to determine whether Bcl-2 could equally protect sensitive cells from RNI-dependent apoptosis within the context of a relevant biologic system such as the delivery of such RNI by activated macrophages. Results demonstrated that transfection of P815 cells with the human bcl-2 gene confers immunity from RNI-dependent, macrophage- mediated cytotoxicity. In contrast with wild-type or mock-transfected P815 cells, which do not contain detectable Bcl-2, bcl-2-transfected cells showed minimal DNA fragmentation and cell membrane failure when cocultured with activated macrophages. Additional findings indicate that Bcl-2 affords the transfected cells almost complete resistance to the DNA-fragmenting effects of chemically generated NO or H202 and partial protection from their cytolytic effects. These findings are consistent with the hypothesis that tumor cells expressing bcl-2 may escape destruction by macrophage-dependent immune surveillance mechanisms.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
K. Kanaoka, Y. Kobayashi, F. Hashimoto, T. Nakashima, M. Shibata, K. Kobayashi, Y. Kato, and H. Sakai
A Common Downstream Signaling Activity of Osteoclast Survival Factors That Prevent Nitric Oxide-Promoted Osteoclast Apoptosis
Endocrinology, August 1, 2000; 141(8): 2995 - 3005.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Geng, R. B. Shane, K. Berencsi, E. Gonczol, M. H. Zaki, D. J. Margolis, G. Trinchieri, and A. H. Rook
Chlamydia pneumoniae Inhibits Apoptosis in Human Peripheral Blood Mononuclear Cells Through Induction of IL-10
J. Immunol., May 15, 2000; 164(10): 5522 - 5529.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. S. Duffield, L.-P. Erwig, X.-q. Wei, F. Y. Liew, A. J. Rees, and J. S. Savill
Activated Macrophages Direct Apoptosis and Suppress Mitosis of Mesangial Cells
J. Immunol., February 15, 2000; 164(4): 2110 - 2119.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Rojas, M. Olivier, P. Gros, L. F. Barrera, and L. F. Garcia
TNF-{alpha} and IL-10 Modulate the Induction of Apoptosis by Virulent Mycobacterium tuberculosis in Murine Macrophages
J. Immunol., May 15, 1999; 162(10): 6122 - 6131.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
T. OZAWA
Mitochondrial DNA Mutations and Age
Ann. N.Y. Acad. Sci., November 20, 1998; 854(1): 128 - 154.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.